Targeted Therapies for Renal Cell Carcinoma: Review of Adverse Event Management Strategies Full Text
Journal of the National Cancer Institute,

Eisen T et al. – The authors identify and summarize clear recommendations for the management of dermatologic, gastrointestinal, thyroid, cardiovascular, and other adverse events (AEs), based predominantly on expert opinion. However, because the evidence for the suggested management strategies is largely anecdotal, there is a need for further systematic investigation of management strategies for AEs related to targeted therapies for renal cell carcinoma (RCC).

Please login or register to follow this author.
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Oncology Articles

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore